Patent Assignment
Reel/Frame 043338/0187
Assignment of Assignor's Interest
Recorded: 2017-08-18
Pages: 5
Assignor
IMPRIMIS PHARMACEUTICALS, INC.
Executed: 2017-07-24
Assignee
ETON PHARMACEUTICALS, INC.
21925 FIELD PARKWAY, SUITE 235, DEER PARK, ILLINOIS, 60010
Covered Properties
(2)
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives
Application:
62/100,368 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jun 16, 2015
From: IMPRIMIS PHARMACEUTICALS, INC.
To: IMMY FUNDING LLC
Reel/Frame 035923/0749 →
Assignment of Assignor's Interest
Jul 10, 2015
From: BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 036093/0286 →
Assignment of Assignor's Interest
Jan 12, 2016
From: BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 037467/0854 →
Assignment of Assignor's Interest
Mar 2, 2016
From: BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 037874/0436 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 35923/0749
Jul 19, 2017
From: IMMY FUNDING LLC
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 043259/0434 →
Intellectual Property Security Agreement
Jul 19, 2017
From: IMPRIMIS PHARMACEUTICALS, INC.
To: SWK FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 043258/0581 →
Assignment of Assignor's Interest
Jul 13, 2018
From: ETON PHARMACEUTICALS, INC.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 046344/0963 →
Change of Name
Jan 7, 2019
From: IMPRIMIS PHARMACEUTICALS, INC.
To: HARROW HEALTH, INC.
Reel/Frame 048019/0161 →
Assignment of Assignor's Interest
Nov 1, 2019
From: HARROW HEALTH, INC.
To: HARROW IP, LLC
Reel/Frame 050903/0404 →
Release of Security Interest
May 7, 2021
From: SWK FUNDING LLC
To: HARROW IP, LLC
Reel/Frame 056174/0332 →